SCH Precongress
Canine and feline congenital portosystemic shunting
Date: Wednesday 20 September
Time: Full day programme of morning lectures and afternoon roundtable discussions 08.30-17.00
Venue: Hotel SB Diagonal Zero, Norte América Room https://www.hoteldiagonalzero.com/en/location/
Registration fee - onsite live precongress (incl on-demand access afterwards): SCH member - €100 | SCH non-member €160 incl. VAT
Closing date for registration is Monday 4 September.
Registration fee - online live & on-demand precongress: SCH member - € 30 | SCH non-member € 90 incl. VAT
Closing date for registration is Monday 18 September
In case of questions concerning the live-stream and on-demand connections and link, please contact the society via comparativehepatology@gmail.com
Registration: Online pre-registration via ECVIM-CA Congress registration or on-demand ECVIM-CA Congress registration
Programme
Lectures (morning)
08.30-09.00 Coffee starter
09.00-09.10 Welcome, sponsor thanking (Royal Canin) and housekeeping
09.10-09.50 cPSS genetics and genetic predictors of outcome | Frank van Steenbeek (Utrecht, Netherlands)
09.50-10.30 cPSS morphology and embryology, including their clinical significance | Mickey Tivers (Wakefield, England)
10.30-11.00 Coffee break
11.00-11.40 Dissecting cPSS complications: HE (including pathogenesis); gastrointestinal haemorrhage | Adam Gow (Edinburgh, Scotland)
11.40-12.20 Biomarkers for cPSS diagnosis and surgical attenuation success assessment: current evidence and clinical significance | Nausikaa Devriendt (Ghent, Belgium)
12.20-13.30 Lunch
Roundtable discussions and Q&A from audience (afternoon)
Panel
Frank van Steenbeek (Utrecht, Netherlands), Mickey Tivers (Wakefield, England), Adam Gow (Edinburgh, Scotland), Nausikaa Devriendt (Ghent, Belgium), Chick Weisse (New York, USA), Gonçalo Serrano (Rijswijk, Netherlands)
13.30
Pros and cons
- Medical vs surgical management: how to arrive at an evidence-based decision on whether to treat a dog or cat with a cPSS medically or surgically?
- Interventional vs non-interventional: which methods achieve best outcome for cIHPSS and cEHPSS, respectively?
cPSS attenuation
- What do you consider before undergoing attenuation?
- Assessing vs not assessing closure post-procedurally
- How and when do you measure post-operative success after surgical attenuation? Which biomarkers or imaging techniques?
15.00-15.30 Coffee break
15.30
How to deal with peri/postoperative complications
- Decide on the value of preoperative use of antiepileptics in management of post-ligation neurological syndrome
- How to deal with acute portal hypertension cases after coiling
Controversies in the medical management and monitoring response to treatment
- Discuss the nutritional management of young growing dogs with hepatic supportive diets
- Decide on the use of antibiotics on the long-term of medical therapy
- Discuss the use of proton pump inhibitors before and after cIHPSS attenuation
- When to stop medical therapy after surgery?
16.40-17.00 Final questions, thank you and goodbye
For more information on renewing your membership or if you’re interested in joining the SCH, please go to https://comparativehepatology.org/
Please contact us by email (comparativehepatology@gmail.com) if you experience any PayPal account issues when paying for membership